Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

Budoprutug receives FDA Fast Track status for primary membranous nephropathy after phase 1b data demonstrate clinical activity and safety.

Candidemia is an infrequent but severe complication after solid organ transplantation associated with a substantial mortality burden.

(HealthDay News) — Childhood cancer is the eighth leading cause of childhood death globally, with improvements in deaths due to childhood cancer seen in some countries since 1990, according to a study ...

Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a stu ...

203 kava exposures reported in 2025; reports involving combined use of kava and kratom reached 30 percent of all kava reports in 2025.

Older adults with unmet dental needs due to cost have higher incidence of heart failure, MI, stroke, dementia.

Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.

Black patients with chronic kidney diseases have faced historically longer waiting times for kidney transplants due to an ...